Our hospital is equipped with a wide range of advanced instruments and devices from Germany, the United States, Japan, the Netherlands, and other countries

Accuracy M6 CyberKnife from the U.S. (the first in Foshan)
Varian new-generation Vital Beam linear accelerator from the U.S.
Siemens dual source CT from Germany
Leonardo’s robot from the U.S.
Siemens PET-CT from Germany
Siemens 3.0 MRI from Germany
TiRobot

Seven frontier tumor diagnosis and treatment techniques

"Anti-tumor Black Technology" cyber knife

The unique six- dimensional articulated manipulator of the cyber knife can track tumor displacement arising from respiration in real time under image guidance, thereby avoiding normal tissues where possible. Not only for malignant tumors, it can also treat some benign functional diseases with 3-5 irradiations only

Precision radiotherapy

Precision radiotherapy is a non-invasive radiotherapy that kills tumors efficiently with improved accuracy and a reduced irradiation range as compared to conventional radiotherapies, reducing damage to normal tissues around tumors effectively, and reduces complications significantly.

International multidisciplinary consultation

The consultation team is composed of multidisciplinary experts in medical oncology, radiotherapy, oncological surgery, imaging, pathology, TCM oncology, etc., and conducts consultation with renowned oncologists from the U.S. weekly to develop diagnosis and treatment plans jointly, so that patients can receive high-quality international medical services in oncology locally.

Precise diagnosis and treatment of pulmonary nodules

The pulmonary Nodule Precise Diagnosis and Treatment center is the Foshan office of the china Alliance Against Lung cancer.
It integrates a range of diagnostic techniques such as low-dose lung CT, PET/CT, liquid biopsy, guided lung puncture biopsy system, Al diagnosis, and TCM syndrome differentiation and treatment, as well as comprehensive treatment methods such as Leonardo's robot surgery, guided ablation, and cyber knife.

Electric field therapy

The new treatment technique for malignant cerebral glioblastomas interferes with the mitosis of cancer cells through an alternating electric field to promote apoptosis and inhibits tumor growth. The electric field tumor therapy has minor side effects and rigorously clinically proven effectiveness, and can improve the survival rate of tumor patients considerably.

CAR-T cell therapy

It has introduced China's first CAR-T cell therapy approved by the National Medical products Administration and helped patients of recurrent and refractory DLBCL remove all tumor cells successfully.

PET/CT diagnosis

The world-class Siemens PET/CT system features a high resolution, high sensitivity, fast scanning, etc. and can obtain tomographic images of the whole body in all directions at a time, realizing the early detection of lesions and the early diagnosis of diseases.

Connected with international practices, our hospital actively introduces emerging cutting - edge pharmaceuticals and medical devices. It has become the first medical institution in Foshan designated under the "Hong Kong - Macau Pharmaceutical and Medical Device Pass" scheme

2023 February

Our hospital became the first designated medical institution in Foshan for Hong Kong and Macao Medicine and Equipment

2023 May

Inclisran-the first international new drug for hyperlipidemia treatment in Foshan -was approved for clinical use.

2023 August

Rimegepant - the world's first FDA-approved new drug for both the acute treatment and prevention of migraine - was approved.

2023 August

Tafasitamab for injection for the treatment of recurrent / refractory DLBCL was ap proved.

2023 November

Symplicity SpyralTM radiofrequency ablation (RDN) for the renal artery sympathetic nerve - the world's first interventional therapy for hypertension -was put into clinical application officially.

2023 November

The first batch Of FARAPULSE pulsed electric field ablation surgery in the Chinese mainland was performed for a patient of atrial fibrillation.

2024 May

The Cochlear 0632 -an international new-type cochlear implant -was approved, and the first implantation operation was completed in July.

2024 July

The first recipe for the world's first innovative drug for dry eye - the varenicline tartrate nasal spray - was prescribed at our hospital.

2024 July

The world's first third-generation branded TKI drug was approved, bringing new hope for the treatment of rare leukemia.